Order Article Reprints

Kiseleva I, Isakova-Sivak I, Stukova M, Erofeeva M, Donina S, Larionova N, Krutikova E, Bazhenova E, Stepanova E, Vasilyev K, et al. A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults. Vaccines. 2020; 8(2):296. https://doi.org/10.3390/vaccines8020296

Kiseleva, Irina, Irina Isakova-Sivak, Marina Stukova, Marianna Erofeeva, Svetlana Donina, Natalie Larionova, Elena Krutikova, Ekaterina Bazhenova, Ekaterina Stepanova, Kirill Vasilyev, and et al. 2020. "A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults" Vaccines 8, no. 2: 296. https://doi.org/10.3390/vaccines8020296

Kiseleva, I., Isakova-Sivak, I., Stukova, M., Erofeeva, M., Donina, S., Larionova, N., Krutikova, E., Bazhenova, E., Stepanova, E., Vasilyev, K., Matyushenko, V., Krylova, M., Galatonova, J., Ershov, A., Lioznov, D., Sparrow, E. G., Torelli, G., & Rudenko, L. (2020). A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults. Vaccines, 8(2), 296. https://doi.org/10.3390/vaccines8020296